Title : Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options.

Pub. Date : 2004 Jul

PMID : 15230850






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The combination of pegylated IFNa and ribavirin seems to be a rational approach for patients who failed to respond to IFNa monotherapy. Ribavirin interferon alpha 1 Homo sapiens
2 Pegylated IFNa-based regimens appear to induce sustained responses in 40-68% of relapsers but in only 11% of nonresponders to previous therapy with standard IFNa plus ribavirin. Ribavirin interferon alpha 1 Homo sapiens